A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Life Spine Announces First Surgical Cases of DYNA-LINK® Titanium With Barb Fixation

Life Spine notes DYNA-LINK Titanium Stand-Alone Anterior Lumbar System is a zero-profile, stand-alone device that offers surgeons a safe and reliable alternative to 360˚ fusion procedures. In addition to providing immediate fixation, multiple footprints, heights, screw options, and now barbs are available to accommodate various patient anatomies and pathologies to promote fusion.

“DYNA-LINK Titanium Barb offering provides an integrated supplemental fixation system that allows for a less invasive direct anterior approach. Barbs are preloaded within the inserter for the titanium implant, permitting seamless deployment of fixation for the cage and eliminating the need for angulated instruments,” said Dr. Ali Mesiwala of the DISC Sports & Spine Center in Newport Beach, California. “This potentially reduces surgical time and incision size and provides an ideal option to treat my patients in both the outpatient and inpatient setting.”

DYNA-LINK Titanium Features and Benefits:

  • Stand-Alone Device *barbs require supplemental fixation
  • Streamlined Barb Delivery Instrumentation
  • Osseo-Loc® Surface Technology
  • 37˚ to 45˚ Screw Angulation
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy